DNA adduct and mutation analysis in white blood cells of smokers and nonsmokers
β Scribed by Dr. J. M. S. Van Maanen; L. M. Maas; G. Hageman; J. C. S. Kleinjans; B. Van Agen
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 480 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0893-6692
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Purified DNA from human lung, liver, bladder, pancreas, breast and cervix has been analysed for DNA adducts using the nuclease P, modification of the 32P post-labelling technique. Tissues were obtained at autopsy from 13 men and 6 women. Relatives were asked to provide information on smoking history
Individuals differ widely in their ability to repair DNA damage, and DNA-repair deficiency may be involved in modulating cancer risk. In a case-control study of 124 bladder-cancer patients and 85 hospital controls (urological and non-urological), 3 DNA polymorphisms localized in 3 genes of different
## Abstract Mounting evidence has suggested somatic mutations in the __EGFR__ gene are associated with better responsiveness to __EGFR__ tyrosine kinase inhibitors (TKIs) in patients with nonβsmallβcell lung cancer (NSCLC). Some, but not all, studies have reported that the mutations were more frequ
Glutathione S-transferases (GSTs) are an important part of the protection system against a wide range of potentially harmful chemical compounds. GSTP1 and GSTM1 are mainly involved in detoxification reactions of PAH carcinogenic intermediates produced by cytochrome P450 (CYP). Polymorphism of the GS